In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Albaglos SF Drug Master File in Korea (Albaglos SF KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Albaglos SF. The MFDS reviews the Albaglos SF KDMF as part of the drug registration process and uses the information provided in the Albaglos SF KDMF to evaluate the safety and efficacy of the drug.
After submitting a Albaglos SF KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Albaglos SF API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Albaglos SF suppliers with KDMF on PharmaCompass.